 |
PDBsum entry 1bqu
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1bqu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
17:1665-1674
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a cytokine-binding region of gp130.
|
|
J.Bravo,
D.Staunton,
J.K.Heath,
E.Y.Jones.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of the cytokine-binding homology region of the cell surface
receptor gp130 has been determined by X-ray crystallography at 2.0 A resolution.
The beta sandwich structure of the two domains conforms to the topology of the
cytokine receptor superfamily. This first structure of an uncomplexed receptor
exhibits a similar L-shaped quaternary structure to that of ligand-bound family
members and suggests a limited flexibility in relative domain orientation of
some 3 degrees. The putative ligand-binding loops are relatively rigid, with a
phenylalanine side chain similarly positioned to exposed aromatic residues
implicated in ligand binding for other such receptors. The positioning and
structure of the N-terminal portion of the polypeptide chain have implications
for the structure and function of cytokine receptors, such as gp130, which
contain an additional N-terminal immunoglobulin-like domain.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3 Gp130-CHR domain 2 and interdomain linker. (A)
Schematic diagram of the WSXWS box. The side chains of residues
contributing to this structural feature are colour coded
according to the secondary structure element from which they
originate. (B) Atomic coordinates and electron density map for
the WSXWS box. The refined coordinates are displayed with the
original 2.9 Å resolution electron density map calculated using
MAD phases followed by density modification (program DM, see
Materials and methods). The map is contoured at 1 in
program O. (C) Schematic diagram of the D1 -D2 linker region.
Strand L in the linker region hydrogen-bonds to strand A in DL
and the WSXWS box region of the polypeptide chain prior to the
start of strand G in D2.
|
 |
Figure 5.
Figure 5 The putative ligand-binding region in gp130-CHR
compared with hGHR. Two orthogonal views are shown for gp130-CHR
(green) and hGHR (yellow). Loops implicated in ligand binding
for the hGH -hGHR complex, and their equivalents in the
gp130-CHR structure, are denoted in red. The side chains of the
structurally equivalent residues Phe169 and Trp104 are shown in
ball and stick representation.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(1998,
17,
1665-1674)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.N.Kostjukova,
and
N.N.Tupitsyn
(2011).
Functional Properties of Extracellular Domains of Transducer Receptor gp130.
|
| |
Biochemistry (Mosc),
76,
394-406.
|
 |
|
|
|
|
 |
S.Indu,
V.Kochat,
S.Thakurela,
C.Ramakrishnan,
and
R.Varadarajan
(2011).
Conformational analysis and design of cross-strand disulfides in antiparallel β-sheets.
|
| |
Proteins,
79,
244-260.
|
 |
|
|
|
|
 |
G.H.Waetzig,
A.Chalaris,
P.Rosenstiel,
J.Suthaus,
C.Holland,
N.Karl,
L.Vallés Uriarte,
A.Till,
J.Scheller,
J.Grötzinger,
S.Schreiber,
S.Rose-John,
and
D.Seegert
(2010).
N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130.
|
| |
J Biol Chem,
285,
1781-1789.
|
 |
|
|
|
|
 |
H.Walden
(2010).
Selenium incorporation using recombinant techniques.
|
| |
Acta Crystallogr D Biol Crystallogr,
66,
352-357.
|
 |
|
|
|
|
 |
X.Wang,
P.Lupardus,
S.L.Laporte,
and
K.C.Garcia
(2009).
Structural biology of shared cytokine receptors.
|
| |
Annu Rev Immunol,
27,
29-60.
|
 |
|
|
|
|
 |
F.Rousseau,
S.Chevalier,
C.Guillet,
E.Ravon,
C.Diveu,
J.Froger,
F.Barbier,
L.Grimaud,
and
H.Gascan
(2008).
Ciliary Neurotrophic Factor, Cardiotrophin-like Cytokine, and Neuropoietin Share a Conserved Binding Site on the Ciliary Neurotrophic Factor Receptor {alpha} Chain.
|
| |
J Biol Chem,
283,
30341-30350.
|
 |
|
|
|
|
 |
Q.Zhang,
P.Putheti,
Q.Zhou,
Q.Liu,
and
W.Gao
(2008).
Structures and biological functions of IL-31 and IL-31 receptors.
|
| |
Cytokine Growth Factor Rev,
19,
347-356.
|
 |
|
|
|
|
 |
R.Matadeen,
W.C.Hon,
J.K.Heath,
E.Y.Jones,
and
S.Fuller
(2007).
The dynamics of signal triggering in a gp130-receptor complex.
|
| |
Structure,
15,
441-448.
|
 |
|
|
|
|
 |
T.Huyton,
J.G.Zhang,
C.S.Luo,
M.Z.Lou,
D.J.Hilton,
N.A.Nicola,
and
T.P.Garrett
(2007).
An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor.
|
| |
Proc Natl Acad Sci U S A,
104,
12737-12742.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Diveu,
E.Venereau,
J.Froger,
E.Ravon,
L.Grimaud,
F.Rousseau,
S.Chevalier,
and
H.Gascan
(2006).
Molecular and functional characterization of a soluble form of oncostatin M/interleukin-31 shared receptor.
|
| |
J Biol Chem,
281,
36673-36682.
|
 |
|
|
|
|
 |
M.Kawahara,
Y.Ogo,
K.Tsumoto,
I.Kumagai,
H.Ueda,
and
T.Nagamune
(2006).
Growth control of hybridoma cells with an artificially induced EpoR-gp130 heterodimer.
|
| |
Cytotechnology,
52,
171-179.
|
 |
|
|
|
|
 |
M.Shiroishi,
M.Kajikawa,
K.Kuroki,
T.Ose,
D.Kohda,
and
K.Maenaka
(2006).
Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11).
|
| |
J Biol Chem,
281,
19536-19544.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Skiniotis,
M.J.Boulanger,
K.C.Garcia,
and
T.Walz
(2005).
Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
|
| |
Nat Struct Mol Biol,
12,
545-551.
|
 |
|
|
|
|
 |
D.Man,
W.He,
K.H.Sze,
K.Gong,
D.K.Smith,
G.Zhu,
and
N.Y.Ip
(2003).
Solution structure of the C-terminal domain of the ciliary neurotrophic factor (CNTF) receptor and ligand free associations among components of the CNTF receptor complex.
|
| |
J Biol Chem,
278,
23285-23294.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Plun-Favreau,
D.Perret,
C.Diveu,
J.Froger,
S.Chevalier,
E.Lelièvre,
H.Gascan,
and
M.Chabbert
(2003).
Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
|
| |
J Biol Chem,
278,
27169-27179.
|
 |
|
|
|
|
 |
J.Nicholas
(2003).
Human herpesvirus-8-encoded signalling ligands and receptors.
|
| |
J Biomed Sci,
10,
475-489.
|
 |
|
|
|
|
 |
M.J.Boulanger,
A.J.Bankovich,
T.Kortemme,
D.Baker,
and
K.C.Garcia
(2003).
Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130.
|
| |
Mol Cell,
12,
577-589.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.J.Boulanger,
D.C.Chow,
E.E.Brevnova,
and
K.C.Garcia
(2003).
Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.
|
| |
Science,
300,
2101-2104.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.E.Willcox,
L.M.Thomas,
T.L.Chapman,
A.P.Heikema,
A.P.West,
and
P.J.Bjorkman
(2002).
Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.
|
| |
BMC Struct Biol,
2,
6.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Cebo,
V.Durier,
P.Lagant,
E.Maes,
D.Florea,
T.Lefebvre,
G.Strecker,
G.Vergoten,
and
J.P.Zanetta
(2002).
Function and molecular modeling of the interaction between human interleukin 6 and its HNK-1 oligosaccharide ligands.
|
| |
J Biol Chem,
277,
12246-12252.
|
 |
|
|
|
|
 |
C.Guillet,
E.Lelièvre,
H.Plun-Favreau,
J.Froger,
M.Chabbert,
J.Hermann,
A.Benoit de Coignac,
J.Y.Bonnefoy,
H.Gascan,
J.F.Gauchat,
and
G.Elson
(2002).
Functionally active fusion protein of the novel composite cytokine CLC/soluble CNTF receptor.
|
| |
Eur J Biochem,
269,
1932-1941.
|
 |
|
|
|
|
 |
H.Li,
and
J.Nicholas
(2002).
Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.
|
| |
J Virol,
76,
5627-5636.
|
 |
|
|
|
|
 |
K.Morikawa
(2002).
[Ligand recognition mechanism of G-CSF receptor and metabotropic glutamate receptor]
|
| |
Yakugaku Zasshi,
122,
855-868.
|
 |
|
|
|
|
 |
M.B.Voisin,
J.Bitard,
S.Daburon,
J.F.Moreau,
and
J.L.Taupin
(2002).
Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.
|
| |
J Biol Chem,
277,
13682-13692.
|
 |
|
|
|
|
 |
D.Chow,
X.He,
A.L.Snow,
S.Rose-John,
and
K.C.Garcia
(2001).
Structure of an extracellular gp130 cytokine receptor signaling complex.
|
| |
Science,
291,
2150-2155.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Li,
H.Wang,
and
J.Nicholas
(2001).
Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling.
|
| |
J Virol,
75,
3325-3334.
|
 |
|
|
|
|
 |
M.Kawahara,
A.Natsume,
S.Terada,
K.Kato,
K.Tsumoto,
I.Kumagai,
M.Miki,
W.Mahoney,
H.Ueda,
and
T.Nagamune
(2001).
Replacing factor-dependency with that for lysozyme: affordable culture of IL-6-dependent hybridoma by transfecting artificial cell surface receptor.
|
| |
Biotechnol Bioeng,
74,
416-423.
|
 |
|
|
|
|
 |
P.D.Carr,
S.E.Gustin,
A.P.Church,
J.M.Murphy,
S.C.Ford,
D.A.Mann,
D.M.Woltring,
I.Walker,
D.L.Ollis,
and
I.G.Young
(2001).
Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration.
|
| |
Cell,
104,
291-300.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.E.Gustin,
A.P.Church,
S.C.Ford,
D.A.Mann,
P.D.Carr,
D.L.Ollis,
and
I.G.Young
(2001).
Expression, crystallization and derivatization of the complete extracellular domain of the beta(c) subunit of the human IL-5, IL-3 and GM-CSF receptors.
|
| |
Eur J Biochem,
268,
2905-2911.
|
 |
|
|
|
|
 |
C.Olivier,
P.Auguste,
M.Chabbert,
E.Lelièvre,
S.Chevalier,
and
H.Gascan
(2000).
Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
|
| |
J Biol Chem,
275,
5648-5656.
|
 |
|
|
|
|
 |
G.Müller-Newen,
A.Küster,
J.Wijdenes,
F.Schaper,
and
P.C.Heinrich
(2000).
Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies.
|
| |
J Biol Chem,
275,
4579-4586.
|
 |
|
|
|
|
 |
J.Bravo,
and
J.K.Heath
(2000).
Receptor recognition by gp130 cytokines.
|
| |
EMBO J,
19,
2399-2411.
|
 |
|
|
|
|
 |
J.M.Matthews,
R.S.Norton,
A.Hammacher,
and
R.J.Simpson
(2000).
The single mutation Phe173 --> Ala induces a molten globule-like state in murine interleukin-6.
|
| |
Biochemistry,
39,
1942-1950.
|
 |
|
|
|
|
 |
M.C.Deller,
K.R.Hudson,
S.Ikemizu,
J.Bravo,
E.Y.Jones,
and
J.K.Heath
(2000).
Crystal structure and functional dissection of the cytostatic cytokine oncostatin M.
|
| |
Structure,
8,
863-874.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.L.Chapman,
A.P.Heikema,
A.P.West,
and
P.J.Bjorkman
(2000).
Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
|
| |
Immunity,
13,
727-736.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.R.Cole,
N.E.Hall,
H.R.Treutlein,
J.S.Eddes,
G.E.Reid,
R.L.Moritz,
and
R.J.Simpson
(1999).
Disulfide bond structure and N-glycosylation sites of the extracellular domain of the human interleukin-6 receptor.
|
| |
J Biol Chem,
274,
7207-7215.
|
 |
|
|
|
|
 |
D.G.Myszka
(1999).
Survey of the 1998 optical biosensor literature.
|
| |
J Mol Recognit,
12,
390-408.
|
 |
|
|
|
|
 |
J.Grötzinger,
T.Kernebeck,
K.J.Kallen,
and
S.Rose-John
(1999).
IL-6 type cytokine receptor complexes: hexamer, tetramer or both?
|
| |
Biol Chem,
380,
803-813.
|
 |
|
|
|
|
 |
S.A.Middleton,
F.P.Barbone,
D.L.Johnson,
R.L.Thurmond,
Y.You,
F.J.McMahon,
R.Jin,
O.Livnah,
J.Tullai,
F.X.Farrell,
M.A.Goldsmith,
I.A.Wilson,
and
L.K.Jolliffe
(1999).
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide.
|
| |
J Biol Chem,
274,
14163-14169.
|
 |
|
|
|
|
 |
T.Hage,
W.Sebald,
and
P.Reinemer
(1999).
Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface.
|
| |
Cell,
97,
271-281.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Kernebeck,
S.Pflanz,
G.Müller-Newen,
G.Kurapkat,
R.M.Scheek,
K.Dijkstra,
P.C.Heinrich,
A.Wollmer,
S.Grzesiek,
and
J.Grötzinger
(1999).
The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region.
|
| |
Protein Sci,
8,
5.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Wan,
H.Wang,
and
J.Nicholas
(1999).
Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.
|
| |
J Virol,
73,
8268-8278.
|
 |
|
|
|
|
 |
J.M.Matthews,
A.Hammacher,
G.J.Howlett,
and
R.J.Simpson
(1998).
Physicochemical characterization of an antagonistic human interleukin-6 dimer.
|
| |
Biochemistry,
37,
10671-10680.
|
 |
|
|
|
|
 |
S.Ozbek,
J.Grötzinger,
B.Krebs,
M.Fischer,
A.Wollmer,
T.Jostock,
J.Müllberg,
and
S.Rose-John
(1998).
The membrane proximal cytokine receptor domain of the human interleukin-6 receptor is sufficient for ligand binding but not for gp130 association.
|
| |
J Biol Chem,
273,
21374-21379.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |